Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Eli Lilly and Company Stock Down 1.1 % NYSE LLY opened at $902.71 on Friday. Eli Lilly and Company has a 52 week low of $516.57 and a 52 week high of $972.53. The company has a quick ratio of 0.87 ...

Eli Lilly is about to sell Zepbound for $399 per month direct to consumers. Typically sold in more expensive injector pens, Lilly is offering the drug in vials to get Zepbound to customers more ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Annemarie Conte Annemarie Conte is an editor who writes the Ask ...

Eli Lilly announced Tuesday that it will offer Zepbound in a new, cheaper formulation. Instead of using its standard auto-injector pens, the company will sell vials that can be injected with a ...

Eli Lilly has been rolling out Zepbound in recent months, and demand has been "unbelievable," says the CEO. Sales have been taking off, and that's even without spending aggressively on sales and ...

Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the price of its pens, amid skyrocketing demand among Americans for anti-obesity ...

The vials should be easier to manufacture than the pens and can help improve supply. These cheaper versions of Zepbound will be available through Lilly’s direct-to-consumer website called ...

Zepbound is typically sold in auto-injector pens, but with easier to manufacture and fill vials Lilly will be able to get the drug to patients more quickly. The 2.5 milligram and 5mg vials - the ...

Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses.

Eli Lilly garnered widespread praise Tuesday for launching discounted versions of its blockbuster obesity drug Zepbound. Before, the treatment had only been sold in injectable pens for a list ...